ICOSLG Antikörper (Biotin)

Produktnummer ABIN2661025

Produktdetails anti-ICOSLG Antikörper (Biotin)

Target: ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))

Reaktivität: Maus

Wirt: Ratte

Klonalität: Monoklonal

Konjugat: Dieser ICOSLG Antikörper ist konjugiert mit Biotin

Applikation: Flow Cytometry (FACS)

Aufreinigung: The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions. The solution is free of unconjugated biotin.

Klon: HK5-3

Isotyp: IgG2a kappa

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 0.5 mg/mL

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Do not freeze.

Lagerung: 4 °C

Informationen zur Lagerung: The antibody solution should be stored undiluted between 2°C and 8°C.

Details zu ICOSLG

Target: ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))

Andere Bezeichnung: CD275 (ICOSLG Produkte)

Synonyme: ICOSLG antikoerper, AU044799 antikoerper, B7-H2 antikoerper, B7RP-1 antikoerper, B7h antikoerper, BG071784 antikoerper, GI50 antikoerper, GL50 antikoerper, GL50-B antikoerper, ICOS-L antikoerper, Icoslg antikoerper, LICOS antikoerper, Ly115l antikoerper, mKIAA0653 antikoerper, B7H2 antikoerper, B7RP1 antikoerper, CD275 antikoerper, ICOSL antikoerper, Icosl antikoerper, RGD1562791 antikoerper, inducible T-cell costimulator ligand antikoerper, icos ligand antikoerper, inducible T-cell co-stimulator ligand antikoerper, ICOSLG antikoerper, Icosl antikoerper, Icoslg antikoerper

Hintergrund: CD275 is a 40 kD protein, also known as ICOS ligand, B7-RP1, B7-H2, and B7h. It is a member of the immunoglobulin receptor superfamily expressed on splenic B cells, dendritic cells, and macrophages. The expression of this antigen is increased by TNF-α stimulation and is highly upregulated by local inflammation. B7RP1 binds to ICOS and co-stimulates T cell and B cell responses. Two isoforms of this protein have been reported to occur as a result of alternative splicing. These isoforms show differential tissue distribution.

Pathways: Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation